LB Rethink IVS: Financial statements 2020
CVR: 38122924
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
LB Rethink IVS (CVR 38122924) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 3,345 and a net result of DKK -488 compared with DKK 4,124 the year before. That is a decrease of 74.3% compared with the year before. The profit margin was -14.6%. Equity in the 2020 report amounted to DKK 6. The solvency ratio was 100%.
- Revenue
- DKK 3,345
- Gross Profit
- DKK -439
- Profit/Loss
- DKK -488
- Equity
- DKK 6
- Total Assets
- DKK 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 3K | -439 | -488 | 6 | - |
| 2019 | 13K | 9K | 4K | 494 | - |
| 2018 | 5K | -6K | -8K | 6K | - |
Official annual report
How creditworthy is LB Rethink IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 27, 2020, Stine Bjerringgaard Rasmussen is registered as liquidator of LB Rethink IVS.
As of December 27, 2020, Stine Bjerringgaard Rasmussen has stepped down as adm. dir. of LB Rethink IVS.
On December 27, 2020, LB Rethink IVS entered liquidation.
LB Rethink IVS has published its annual report for 2019. Revenue came to DKK 13,012, and the net result was DKK 4,124.
About LB Rethink IVS
LB Rethink IVS was a Danish company of the type Iværksætterselskab based in Gråsten, founded in 2016. The company has been dissolved on 8 July 2021. The company was registered under the industry Industriel design og produktdesign. In 2020, the company reported revenue of DKK 3,345 and a net result of DKK -488 compared with DKK 4,124 the year before. Equity in the 2020 report amounted to DKK 6.